News | December 22, 2025
CORONA Remedies commissions additional capacity
The additional production will raise the installed capacity by 400 million and available capacity by 240 million at the facility
The additional production will raise the installed capacity by 400 million and available capacity by 240 million at the facility
Additional investments planned to expand the site’s capacity and capabilities to support growing manufacturing programs
The pharma company will donate more than seven tons of its active pharmaceutical ingredient (API) to bolster the American supply chain
These building blocks are essential to modern therapeutics, including fast-growing GLP-1 treatments for weight loss and diabetes
The approval of Augmentin XR, granted to USAntibiotics, directly supports the CNPV program’s goals
The new site will produce next-generation synthetic medicine active pharmaceutical ingredients
The new site marks the company’s first operation in the region
Granules Consumer Health serves as Granules’ front-end division for OTC products in the US
Excelsior aims to make reshoring affordable and strategic, shielding nations from geopolitical disruptions
Implementing PFAS testing in the early development stages allows medical device manufacturers to prepare for potential regulatory updates
Subscribe To Our Newsletter & Stay Updated
